New strategy may target common cancer driver with minimal side effects
Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine. The findings suggest the possibility of a potent, low-side-effect treatment that could benefit many patients with colorectal, breast and other cancer types.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
New strategy exploits a hidden genetic vulnerability in multiple cancers
United Kingdom
-
Extreme heat may raise suicide risk by disrupting sleep and emotional regulation, study finds
United Kingdom
-
Researchers identify strategy to make pediatric bone cancers more vulnerable to immunotherapy
United Kingdom
-
Simple conversational tool identifies dementia risk in developing countries
United Kingdom
-
Exploring sex differences in how the brain adapts to overeating
United Kingdom
-
Rapid genome sequencing helps guide care for about 50% of children with cancer
United Kingdom
-
After adult-onset hearing loss, an adaptation in the brain may improve vision
United Kingdom
-
Tracking loneliness, depression, and social behaviors in children from disaster-affected community
United Kingdom